Study links lung cancer death to menopause hormones

Google News

May 30, 2009

ORLANDO, Florida (AFP) — Hormonal therapy for menopause, already linked to an increase in breast cancer and strokes, also strongly increases the risk of death among women who develop lung cancer, said research released Saturday.

The findings are based on secondary analyses of a study of 16,608 menopausal women in good health by the US government known as the Women’s Health Initiative.

Researchers sought to evaluate the effects of Prempro, a combination of estrogen and progestin (a synthetic form of progesterone), sold by the US pharmaceutical Wyeth.

The analysis focused on the incidence of the most common form of lung cancer and its mortality rate over a period of nearly 5.5 years comparing women who followed the hormonal treatment and another group that took placebos.

There was no significant difference between the two groups in the rate of lung cancer, but the mortality rate after the diagnosis was two times higher among the women that were following hormonal therapy.



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.